| Line Item | 2023-12-30 | Y/Y |
|---|---|---|
| Revenue | $26.64B | +0.6% |
| Cost of Revenue | $17.71B | -3.5% |
| Gross Profit | $8.93B | +9.9% |
| R&D Expense | $147.0M | +15.7% |
| SG&A Expense | $4.35B | -3.0% |
| Operating Income | $4.57B | +25.8% |
| Interest Expense | $912.0M | -1.0% |
| Pre-tax Income | $3.63B | +22.5% |
| Income Tax | $787.0M |
| Line Item | 2023-12-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.40B | +34.6% |
| Accounts Receivable | $2.11B | -0.4% |
| Inventory | $3.61B | -1.0% |
| Current Assets | $7.93B | +0.4% |
| Total Assets | $90.34B | -0.2% |
| Current Liabilities | $8.04B | -11.0% |
| Long-term Debt | $19.39B | +0.8% |
| Line Item | 2023-12-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.98B | +61.0% |
| Capital Expenditures | $1.01B | +10.6% |
| Investing Cash Flow | -$916.0M | +16.0% |
| Financing Cash Flow | -$2.68B | +27.9% |
| Free Cash Flow | $2.96B | +90.8% |
| +31.6% |
| Net Income | $2.85B | +20.8% |
| EPS (Basic) | $2.33 | +20.7% |
| EPS (Diluted) | $2.31 | +20.9% |
| Total Liabilities |
| $40.62B |
| -2.5% |
| Stockholders' Equity | $49.53B | +1.7% |